Krsnaa Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Krsnaa Diagnostics has a total shareholder equity of ₹9.2B and total debt of ₹2.9B, which brings its debt-to-equity ratio to 31%. Its total assets and total liabilities are ₹15.1B and ₹5.8B respectively. Krsnaa Diagnostics's EBIT is ₹1.2B making its interest coverage ratio 12.6. It has cash and short-term investments of ₹1.3B.
Key information
30.96%
Debt to equity ratio
₹2.86b
Debt
| Interest coverage ratio | 12.6x |
| Cash | ₹1.30b |
| Equity | ₹9.23b |
| Total liabilities | ₹5.84b |
| Total assets | ₹15.07b |
Recent financial health updates
Recent updates
Narrative Update • Apr 24
KRSNAA: Board And Interim CFO Changes Will Support Bullish Outlook
Analysts have maintained the fair value estimate for Krsnaa Diagnostics at ₹682, citing only minor adjustments to revenue growth assumptions, profit margin outlook, and the future P/E multiple that do not materially change their valuation view. What's in the News Krsnaa Diagnostics plans a Board meeting on April 17, 2026, to consider multiple governance changes, including the appointment of two additional independent directors, re appointment of an existing independent director, changes in whole time and independent director tenures, and reconstitution of Board committees (company filing).Narrative Update • Apr 08
KRSNAA: Steady View Will Highlight CFO Exit As Key Catalyst
Analysts have kept the price target for Krsnaa Diagnostics steady at ₹682. They cite only slight adjustments in their assumptions for revenue growth, profit margin and future P/E as the main reasons for maintaining this view.Narrative Update • Mar 25
KRSNAA: Steady Outlook Will Spotlight Upcoming Meetings And CFO Transition
Analysts have kept the price target for Krsnaa Diagnostics unchanged at ₹682, citing only small adjustments to projected revenue growth, profit margin and future P/E assumptions that do not materially alter their overall view. What's in the News A special or extraordinary shareholders meeting is scheduled for April 16, 2026, to be conducted via postal ballot in India (company filing).Narrative Update • Mar 10
KRSNAA: Steady Fair Value Will Highlight Upcoming Board And Management Changes
Analysts have maintained their price target for Krsnaa Diagnostics at ₹682, citing only limited tweaks to their models around revenue growth, profit margin and forward P/E assumptions rather than any material change in their outlook. What's in the News A board meeting is scheduled on February 5, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).Narrative Update • Feb 23
KRSNAA: Stable Fair Value And Board Developments Will Guide A Cautious Outlook
Analysts are keeping their price target for Krsnaa Diagnostics steady at ₹682, reflecting relatively unchanged fair value and discount rate assumptions. Only small adjustments have been made to revenue growth, profit margin and future P/E inputs.Narrative Update • Feb 09
KRSNAA: Board Changes And Revised Assumptions Will Shape A Measured Outlook
Analysts have revised their price target for Krsnaa Diagnostics to ₹682.0 from ₹803.5, citing updated assumptions around revenue growth, profit margins and a higher future P/E multiple as key drivers of the change. What's in the News A board meeting is scheduled for February 5, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).Analysis Article • Feb 08
Krsnaa Diagnostics Limited Just Missed EPS By 23%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Krsnaa Diagnostics Limited ( NSE:KRSNAA ), which a week ago released some...Narrative Update • Dec 13
KRSNAA: Board Actions And Stable Margins Will Shape A Measured Outlook
Narrative Update Analysts have trimmed their price target on Krsnaa Diagnostics from ₹949 to ₹803.5, reflecting a more conservative valuation multiple, even as forecasts for revenue growth and profit margins remain broadly resilient. What's in the News Board meeting scheduled for November 7, 2025, to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Analysis Article • Nov 15
Are Investors Undervaluing Krsnaa Diagnostics Limited (NSE:KRSNAA) By 50%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Krsnaa Diagnostics fair value estimate is ₹1,601 Current share...Analysis Article • Sep 30
Returns At Krsnaa Diagnostics (NSE:KRSNAA) Are On The Way Up
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Narrative Update • Sep 04
Rajasthan PPP And Retail Expansion Will Shape Healthcare Future
Krsnaa Diagnostics’ consensus price target saw a minor decrease to ₹1,098, as analysts balanced a slight improvement in revenue growth forecasts with a lower future P/E multiple. What's in the News Board meeting scheduled to approve Q1 FY26 financial results and finalize the Director's report and AGM notice.Analysis Article • Sep 04
Krsnaa Diagnostics (NSE:KRSNAA) Is Increasing Its Dividend To ₹2.75
The board of Krsnaa Diagnostics Limited ( NSE:KRSNAA ) has announced that it will be paying its dividend of ₹2.75 on...Analysis Article • Aug 14
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Will Be Increased To ₹2.75
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) has announced that it will be increasing its dividend from last year's...Analysis Article • Jul 18
Krsnaa Diagnostics Limited (NSE:KRSNAA) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) shares have had a really impressive month, gaining 26% after a shaky period...Analysis Article • May 17
Earnings Miss: Krsnaa Diagnostics Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that Krsnaa Diagnostics Limited ( NSE:KRSNAA ) filed its annual result this time last...Analysis Article • Mar 21
There's Been No Shortage Of Growth Recently For Krsnaa Diagnostics' (NSE:KRSNAA) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Analysis Article • Feb 17
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) just released its latest third-quarter report and things are not looking...
New Narrative • Feb 06
Expansion Into Underpenetrated Markets Will Increase Access To Advanced Diagnostic Services
Expansion into Tier 2 and 3 cities and strategic partnerships in healthcare sectors are expected to drive revenue growth and improve profit margins.Analysis Article • Nov 26
After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) shares have continued their recent momentum with a 30% gain in the last month...Analysis Article • Sep 06
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) has announced that on 21st of October, it will be paying a dividend of₹2.50...Analysis Article • Aug 23
Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) has announced that on 21st of October, it will be paying a dividend of₹2.50...Analysis Article • Aug 10
Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
It's been a good week for Krsnaa Diagnostics Limited ( NSE:KRSNAA ) shareholders, because the company has just released...Analysis Article • Aug 09
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) is reducing its dividend from last year's comparable payment to ₹2.50 on the...Analysis Article • Jul 05
Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) shareholders would be excited to see that the share price has had a great...Analysis Article • Jun 16
Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Analysis Article • May 26
We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
Krsnaa Diagnostics Limited's ( NSE:KRSNAA ) recent weak earnings report didn't cause a big stock movement. Our analysis...Analysis Article • Mar 14
Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Feb 16
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Krsnaa Diagnostics Limited ( NSE:KRSNAA ) shareholders are probably feeling a little disappointed, since its shares...Analysis Article • Aug 31
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Krsnaa Diagnostics Limited's ( NSE:KRSNAA ) dividend will be increasing from last year's payment of the same period to...Analysis Article • Aug 17
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Krsnaa Diagnostics Limited's ( NSE:KRSNAA ) dividend will be increasing from last year's payment of the same period to...Analysis Article • Jun 03
Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Analysis Article • Feb 17
Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
It's been a mediocre week for Krsnaa Diagnostics Limited ( NSE:KRSNAA ) shareholders, with the stock dropping 13% to...Financial Position Analysis
Short Term Liabilities: KRSNAA's short term assets (₹5.8B) exceed its short term liabilities (₹4.1B).
Long Term Liabilities: KRSNAA's short term assets (₹5.8B) exceed its long term liabilities (₹1.8B).
Debt to Equity History and Analysis
Debt Level: KRSNAA's net debt to equity ratio (16.9%) is considered satisfactory.
Reducing Debt: KRSNAA's debt to equity ratio has reduced from 87.9% to 31% over the past 5 years.
Debt Coverage: KRSNAA's debt is well covered by operating cash flow (41.8%).
Interest Coverage: KRSNAA's interest payments on its debt are well covered by EBIT (12.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/13 11:54 |
| End of Day Share Price | 2026/05/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Krsnaa Diagnostics Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hrishikesh Patole | 360 ONE Capital Market Private Limited |
| Bharat Celly | Equirus Securities Private Limited |
| null null | Equirus Securities Private Limited |